Biohit Oyj (LTS:0DRP) Operating Margin %: 21.69% (As of Dec. 2025)


LTS:0DRP Biohit Oyj LTS:0DRP
78 GF Score
Price €2.47
GF Value €2.69
Valuation Fairly Valued
! 4 Warning Signs
View Full Analysis

What is Biohit Oyj Operating Margin %?

Biohit Oyj LTS:0DRP -2.95% 78 Operating Margin % is 21.69% as of Dec. 2025. GuruFocus rates LTS:0DRP with a GF Score™ of 78/100 and a GF Value™ of €2.69 (Fairly Valued). The stock has 4 warning signs investors should review. Among 816 Medical Devices & Instruments companies, Biohit Oyj ranks better than 84.8% on this metric.

Operating Margin % is calculated as Operating Income divided by its Revenue. Biohit Oyj's Operating Income for the six months ended in Dec. 2025 was €1.80 Mil. Biohit Oyj's Revenue for the six months ended in Dec. 2025 was €8.30 Mil. Therefore, Biohit Oyj's Operating Margin % for the quarter that ended in Dec. 2025 was 21.69%.

The historical rank and industry rank for Biohit Oyj's Operating Margin % or its related term are showing as below:

LTS:0DRP' s Operating Margin % Range Over the Past 10 Years
Min: -44.57   Med: -15.04   Max: 20.39
Current: 19.11


LTS:0DRP's Operating Margin % is ranked better than
84.8% of 816 companies
in the Medical Devices & Instruments industry
Industry Median: 3.465 vs LTS:0DRP: 19.11

Biohit Oyj's 5-Year Average Operating Margin % Growth Rate was 0.00% per year.

Biohit Oyj's Operating Income for the six months ended in Dec. 2025 was €1.80 Mil. Its Operating Income for the trailing twelve months (TTM) ended in Dec. 2025 was €3.00 Mil.


Biohit Oyj  (LTS:0DRP) Operating Margin % Explanation

Just like Gross Margin %, it is important to see a company maintains its operating margin over time. Among the same industry, a company with higher operating margin is more efficient in its operation. It is also more stable during industry slowdown or recessions. Peter Lynch prefers those with higher margins than those with lower margins.


Be Aware

Operating Margin % can be manipulated by adjusting the rate of depreciation, depletion and amortization (DDA).

If a company is facing competition, its Operating Margin % may decline. Often the Operating Margin % declines well before the company's Revenue or even profit decline. Therefore, Operating Margin % is a very important indicator of whether the company is facing problems.

For instance, by 2012, Nokia (NOK)'s problems were well known and its stock had lost more than 90% of its market value since 2007. But Nokia’s Operating Margin % had already been in decline since 2002, although its Earnings per Share (Diluted) were still rising. Investors who paid attention to Operating Margin % would have avoided this huge loss. The same can be said for Research-in-Motion (RIMM).

Therefore, Operating Margin % is a very important screening filter for GuruFocus. GuruFocus's Buffett-Munger screener requires that the profit margin is either consistent or expanding. The Model Portfolio of the Buffett-Munger screener has outperformed the market every year since inception in 2009.


Biohit Oyj Operating Margin % Related Terms


Biohit Oyj Operating Margin % Historical Data

* Premium members only.

The historical data trend for Biohit Oyj's Operating Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Biohit Oyj Operating Margin % Chart

Biohit Oyj Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Operating Margin %
Get a 7-Day Free Trial Premium Member Only Premium Member Only -16.03 10.31 13.96 17.90 20.39

Biohit Oyj Semi-Annual Data
Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Operating Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 6.06 17.57 17.39 16.22 21.69

LTS:0DRP vs ABT, SYK, MDT: Operating Margin % Comparison

For the Medical Devices subindustry, Biohit Oyj's Operating Margin %, along with its competitors' market caps and Operating Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Biohit Oyj Operating Margin % vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Biohit Oyj's Operating Margin % distribution charts can be found below:

* The bar in red indicates where Biohit Oyj's Operating Margin % falls into.


LTS:0DRP
78GF Score
Biohit Oyj LTS:0DRP
Operating Margin % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Biohit Oyj Operating Margin % Calculation

Operating Margin % - also known as operating income margin, operating profit margin and return on sales (ROS) - is the ratio of Operating Income divided by net sales or Revenue, usually presented in percent.

Biohit Oyj's Operating Margin % for the fiscal year that ended in Dec. 2025 is calculated as

Operating Margin %=Operating Income (A: Dec. 2025 ) / Revenue (A: Dec. 2025 )
=3.208 / 15.732
=20.39 %

Biohit Oyj's Operating Margin % for the quarter that ended in Dec. 2025 is calculated as

Operating Margin %=Operating Income (Q: Dec. 2025 ) / Revenue (Q: Dec. 2025 )
=1.8 / 8.3
=21.69 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Operating Margin % →
What does a Operating Margin % of 21.69% mean?
Biohit Oyj (LTS:0DRP) has a Operating Margin % of 21.69% as of Dec. 2025. Operating margin is the ratio of total operating income to net sales. View historical data on Biohit Oyj and its competitors. According to the industry distribution chart, Biohit Oyj ranks #124 out of 816 companies in the Medical Devices & Instruments industry, placing it in the top 15.2%.
Is Biohit Oyj's Operating Margin % too high?
Biohit Oyj's current Operating Margin % is 21.69%. The Medical Devices & Instruments industry median Operating Margin % is 3.47. Biohit Oyj's value of 21.69% is 526% above this industry median. Based on the distribution chart, Biohit Oyj ranks #124 out of 816 companies in the Medical Devices & Instruments industry, which is in the top quartile — a strong position relative to peers. Overall, Biohit Oyj has a GF Score™ of 78/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Biohit Oyj's Operating Margin % compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Biohit Oyj ranks #124 out of 816 companies for Operating Margin %. This places Biohit Oyj in the top 15% of its industry — outperforming the majority of peers. The industry median Operating Margin % is 3.47. Biohit Oyj's value of 21.69% is 526% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Operating Margin % for a Medical Devices & Instruments company?
The median Operating Margin % among Medical Devices & Instruments companies is 3.47, based on 816 companies in the industry. Companies in the top quartile (top 25%) have a Operating Margin % significantly above this median, while those in the bottom quartile fall well below. However, Operating Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Biohit Oyj's current Operating Margin % of 21.69% is 526% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Operating Margin % mean?
A high Operating Margin % can signal that a stock is expensive relative to its fundamentals. Operating margin is the ratio of total operating income to net sales. View historical data on Biohit Oyj and its competitors. For the Medical Devices & Instruments industry, the median Operating Margin % is 3.47 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Biohit Oyj's current Operating Margin % is 21.69%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Biohit Oyj stock overvalued right now?
Based on GuruFocus' analysis, Biohit Oyj (LTS:0DRP) is currently considered Fairly Valued. The stock's GF Value™ is €2.69, compared to a current price of €2.47 — trading 8.4% below its estimated fair value. The current Operating Margin % is 21.69% and 526% above the Medical Devices & Instruments industry median of 3.47. Biohit Oyj's overall GF Score™ is 78/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Operating Margin % calculated?
Operating Margin % is calculated from a company's financial statements. For Biohit Oyj (LTS:0DRP), the current Operating Margin % is 21.69% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Biohit Oyj (LTS:0DRP) Overvalued in 2026?

Based on GuruFocus' analysis, Biohit Oyj stock appears to be undervalued. The current stock price of €2.47 is trading 8.4% below its estimated GF Value™ of €2.69. GuruFocus considers Biohit Oyj to be Fairly Valued.

Key valuation signals for LTS:0DRP:

  • Operating Margin %: 21.69%
  • GF Value™: €2.69 vs. price of €2.47 (8.4% below fair value)
  • GF Score™: 78/100 with 4 warning signs
  • Industry Position: 526% above the Medical Devices & Instruments median (#124 of 816)

No single metric tells the full story. See the LTS:0DRP stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Biohit Oyj Business Description

Other Exchanges BIOBV:Finland
Address Laippatie 1, Helsinki, FIN, 00880
Biohit Oyj is a globally operating Finnish biotechnology company that develops diagnostic and other health products. Its products include GastroPanel quick test assesses the structure and function of the stomach lining; ColonView quick test is an immunochemical fecal occult blood test (FIT) developed; Acetium capsules protect the stomach lining from carcinogenic acetaldehyde, especially in people with acid-free stomachs. The company's product portfolio consists of diagnostic tests, analysis systems, products binding carcinogenic acetaldehyde into a harmless compound and monoclonal antibodies.
78GF Score

Get the complete analysis for LTS:0DRP

Operating Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€2.47
Price
€2.69
GF Value